| Literature DB >> 32457680 |
Ciara A Torres1,2, Christopher Medina-Kirchner2, Kate Y O'Malley3,4, Carl L Hart2,3.
Abstract
Background: Despite limited data demonstrating pronounced negative effects of prenatal cannabis exposure, popular opinion and public policies still reflect the belief that cannabis is fetotoxic.Entities:
Keywords: cognition; impairment; marijuana; normative data; prenatal
Year: 2020 PMID: 32457680 PMCID: PMC7225289 DOI: 10.3389/fpsyg.2020.00816
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Figure 1Flowchart of search strategy.
Studies assessing cognition in infants and toddlers (up to 24 months).
| Fried and Watkinson, | OPPS | 12 and 24 month children of women who reported MJ use during pregnancy | MJ use self-reported throughout for each trimester | Relatively small number of participants studied in the heavy MJ-exposed group | ||
| Richardson et al., | MHPCD | 9 and 19 month children of women who reported MJ use during pregnancy | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery for each trimester | When adjusted mean cognitive scores of all groups studied were compared against a normative data set by the authors, they exceeded the average range | ||
| Singer et al., | CWRUS | Up to 2 month children of women who self-reported MJ use during pregnancy: (MJ: | MJ use self-reported at “as soon as possible” post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Singer et al., | CWRUS | 6, 12, and 24 month children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at “as soon as possible” post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Noland et al., | CWRUS | 9 to 12 month children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported 2 weeks post-delivery | No differences were observed | Cognitive scores were not reported | |
| Singer et al., | CWRUS | 6 and 12 month children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported 2 weeks post-delivery | Faster looking times did not relate to visual recognition memory | ||
| Richardson et al., | MHPCD | 16 month children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at 7th pregnancy month and at 24 h post-delivery for each trimester | No differences were observed | Cognitive scores were not reported |
ADJ, Average daily joints; AWJ, Average weekly joints; BSID/BSID-II, Bayley scales of infant development 1st and 2nd editions; CTL, Control group; CWRUS, Case Western Reserve University Study; MHPCD, Maternal Health Practices and the Child Development Study; MJ, Marijuana group; NIAAA, National Institute on Alcohol Abuse and Alcoholism; NIDA, National Institute on Drug Abuse; OPPS, Ottawa Prenatal Prospective Study; THC, Tetrahydrocannabinol.
Negative associations on cognitive outcomes,
Positive associations on cognitive outcomes.
Studies assessing cognition in adolescence and early adulthood (13 to 22 years).
| Fried and Watkinson, | OPPS | 13–16 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy | Heavy prenatal MJ exposure was associated with poorer performance on one of five CPT measures (stability) | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | |
| Fried et al., | OPPS | 13–16 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy | Heavy prenatal MJ exposure was associated with lower spelling recognition scores (PIAT) | PIAT: MJ-exposed participants scores remained within the normal range | |
| Smith et al., | OPPS | 18–22 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported throughout pregnancy | Prenatal MJ exposure group committed more errors of commission for the “Press for all letters except X” condition | Cognitive data not compared against normative data set. Thus, the clinical importance of findings could not be determined | |
| Smith et al., | OPPS | 18–22 year old children of women who reported MJ use during pregnancy (MJ | MJ use self-reported throughout pregnancy | No performance differences were observed | Some (13/31) participants tested positive for MJ. It is unclear whether those reporting MJ use were part of the MJ-exposed or non-exposed group. Participants also reported alcohol and tobacco use, which makes it difficult to assess the effect of MJ | |
| Willford et al., | MHPCD | 16 year old children of women who reported MJ use during: 1st trimester (MJ: | MJ use self-reported at 4th & 7th pregnancy months and at birth | Cognitive data not reported or compared against normative data set. Thus, the clinical importance of findings could not be determined | ||
| Goldschmidt et al., | MHPCD | 14 year old children of women who reported MJ use during: 1st trimester (heavy MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Adjusted cognitive data not reported or compared against normative data set. Thus, the clinical importance of findings could not be determined | ||
| Richardson et al., | MHPCD | 15 year old children of women who reported MJ use during pregnancy (MJ | MJ use self-reported at 7th pregnancy months and at 24–48 h post-delivery | No differences were observed | Cognitive scores were not reported | |
| Smith et al., | OPPS | 18–22 year old children of women who reported MJ use during pregnancy (MJ | MJ use self-reported throughout pregnancy | No differences were observed | Some participants tested positive for MJ. It is unclear whether those reporting MJ use were part of the MJ-exposed or non-exposed group. Participants also reported alcohol and tobacco use but this was controlled for |
ADJ, Average daily joints, AWJ, Average weekly joints, BCT, Bimanual coordination task; CPT, Continuous performance test version I; CTL, Control group; fMRI, Functional magnetic resonance imaging; IQ, Intelligence Quotient; MHPCD, Maternal Health Practices and the Child Development Study; MJ, Marijuana group; NIAAA, National Institute on Alcohol Abuse and Alcoholism; NIDA, National Institute on Drug Abuse; OPPS, Ottawa Prenatal Prospective Study; PIAT, Peabody individual achievement test; WAIS, Weschler adult intelligence scale; WCST-CV/WCST-CV2, Wisconsin card sorting test-computer versions I and II; WIAT, Wechsler individual achievement test 1st edition; WISC/WISC-III, Wechsler intelligence scale for children 1st and 3rd edition; WRAT, Wide range achievement test.
Negative associations on cognitive outcomes,
Positive associations on cognitive outcomes.
Studies assessing cognition in children (3 to 9 years).
| Fried and Watkinson, | OPPS | 3 and 4 year old children of women who reported MJ use during pregnancy | MJ use self-reported throughout pregnancy | Verbal and auditory comprehension/ | ||
| Hayes et al., | UMJS | 4 and 5 year old children of women who reported MJ use during pregnancy: (MJ: | Not explicitly stated, but apparently self-reported MJ use | No differences were observed | Cognitive scores were not reported | |
| O'Connell and Fried, | OPPS | General intelligence [WISC-R, (full scale, verbal and performance IQ, verbal comprehension, perceptual organization and freedom from distractibility subtests)]; | 6 to 9 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported throughout pregnancy | No differences were observed | Mothers reported tobacco cigarette smoking, and alcohol use, but this was controlled for |
| Fried et al., | OPPS | 6 year old children of women who reported MJ use during pregnancy: (heavy MJ: | MJ use self-reported throughout pregnancy | Severity of prenatal MJ use was associated with poorer performance on a measure of impulsivity/sustained attention (Gordon vigilance task, total correct and omissions) | Cognitive data not reported nor compared against normative data set. Thus, the clinical importance of findings could not be determined. | |
| Fried et al., | OPPS | 5 and 6 year old children of women who reported MJ use during pregnancy | MJ use self-reported throughout pregnancy | No differences were observed | Mothers reported tobacco cigarette smoking, and alcohol use, which makes it difficult to assess the effect of MJ | |
| Day et al., | MHPCD | 3 year old children of women who reported MJ use during: 1st trimester (heavy MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Leech et al., | MHPCD | 6 year old children of women who reported MJ use during: 1st trimester (heavy MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Noland et al., | CWRUS | 4 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported 2 weeks post-delivery | No differences were observed | Average maternal verbal IQ score was below the normal range (75.1) | |
| Lewis et al., | CWRUS | 4 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported immediately after delivery | Prenatal MJ exposure group performed more poorly on measure of formulating labels (CELF-P) | Cognitive data not reported nor compared against normative data set. Thus, the clinical importance of findings could not be determined | |
| Frank et al., | BHUS | 48 month children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Noland et al., | CWRUS | 4 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported 2 weeks post-delivery | No differences were observed | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | |
| Beeghly et al., | BHUS | 6 and 9 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Morrow et al., | UMSM | Seven year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported within 36 h post-delivery | No data was reported | Although children were assessed, cognitive scores nor a comparison between MJ and CTL groups were reported | |
| Mayes et al., | YCSC | 8 to 10 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use in last 30 days self-reported prenatally and/or at post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Bennett et al., | DRWJ | 4, 6, and 9 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported prenatally and/or at post-delivery period | No differences were observed | Cognitive scores were not reported | |
| Goldschmidt et al., | MHPCD | 6 year old children of women who reported MJ use during: 1st trimester (heavy MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Adjusted cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Singer et al., | CWRUS | 9 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at post-delivery period for previous month and each trimester | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Richardson et al., | MHPCD | 3 year old children of women who reported MJ use during pregnancy: (MJ: | MJ use self-reported at 7th pregnancy months and/or at 24 h post-delivery | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Carmody et al., | DRWJ | 6 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at either prenatally, at post-delivery period or in mother's home within 2 weeks of child's birth | No differences were observed | Cognitive data not reported |
ADJ, Average daily joints, AWJ, Average weekly joints; BHUS, Boston and Harvard Universities Study; CELF-3, Child evaluation of language fundamentals-third edition; CELF-P, Clinical evaluation of language fundamentals-preschool 1st edition; CPT/CPT-III, Continuous performance test versions I and III; CTL, Control group; CWRUS, Case Western Reserve University Study; DRWJ, Drexel and Robert Wood Johnson Universities Study; DTVMI, Developmental test of visual-motor integration; MHPCD, Maternal Health Practices and the Child Development Study; MJ, Marijuana group; NCRR, National Center for Research Resources; NIAAA, National Institute on Alcohol Abuse and Alcoholism; NIDA, National Institute on Drug Abuse; OPPS, Ottawa Prenatal Prospective Study; PDT; Picture deletion task for preschoolers-modified; SBIS-IV, Stanford-Binet intelligence scale 4th edition; THC, Tetrahydrocannabinol; TOLD-P3, Test of language development-primary third edition; TVPS, Test of visual-perceptual skills; UMJS, University of Miami's Jamaican Study; UMSM, University of Miami School of Medicine Study; WIAT, Wechsler individual achievement test 1st edition; WISC-III/WISC-IV/WISC-R, Wechsler intelligence scale for children 3rd, 4th, and revised editions; WPPSI-R, Wechsler preschool and primary scales of intelligence-revised; WRAT-R, Wide range achievement test-revised; YCSC, Yale Child Study Center.
Negative associations on cognitive outcomes,
Positive associations on cognitive outcomes.
Studies assessing cognition in early adolescence (9 to 12 years).
| Fried et al., | OPPS | 9–12 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy | No differences were observed | Relatively small number of participants studied in the MJ-exposed group | |
| Fried et al., | OPPS | 9–12 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy | Heavy MJ exposure associated with poorer performance on object assembly subtests | Adjusted cognitive scores were not compared against a normative data set. Thus, the clinical importance of findings could not be determined | |
| Fried and Watkinson, | OPPS | 9–12 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy | Prenatal MJ exposure associated with poorer performance on the object assembly subtest | Despite poorer performance on two measures, MJ-exposed participants performed in the normal range on all cognitive tests | |
| Richardson et al., | MHPCD | 10 year old children of women who reported MJ use during: 1st trimester (heavy MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Cognitive scores were not reported or compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Goldschmidt et al., | MHCPD | 10 year old children of women who reported MJ use during: 1st trimester (MJ: | MJ use self-reported at 4th & 7th pregnancy months and at 24–28 h post-delivery | Cognitive scores were not compared against a normative data set. Thus, the clinical importance of findings could not be determined | ||
| Hurt et al., | CHP | 10 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at post-delivery period | No differences were observed | Cognitive data not reported | |
| Hurt et al., | CHP | 12 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at post-delivery period | No differences were observed | Data for a total of 14 cognitive tests were converted into one composite score. Scores for the separate cognitive tasks was not reported. | |
| Lewis et al., | CWRUS | 10 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at post-delivery period | No differences were observed | Cognitive data not reported | |
| Carmody et al., | DRWJ | 9 and 11 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at either prenatally, at post-delivery period or in mother's home within 2 weeks of child's birth | No differences were observed | Cognitive data not reported | |
| Day et al., | MHPCD | 10 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported at 4th & 7th pregnancy months and post-delivery | No differences were observed | Adjusted cognitive data not reported | |
| Rose-Jacobs et al., | BHUS | 12−14 year old children of women who reported MJ use during pregnancy (heavy MJ: | MJ use self-reported throughout pregnancy and shortly after delivery | Moderate, but not heavy, MJ exposure associated with poorer executive functioning (Design fluency: total correct switching) | Average children's scores for most D-KEFS subtests was below the normal range | |
| Rose-Jacobs et al., | BHUS | 11 year old children of women who reported MJ use during pregnancy (MJ: | MJ use self-reported throughout pregnancy and shortly after delivery | Prenatal MJ exposure associated with better academic performance (WIAT-II: spelling) | Adjusted cognitive data not reported |
ADJ, Average daily joints; AWJ, Average weekly joints; BHUS, Boston and Harvard Universities Study; CHP, Children's Hospital of Philadelphia Study; CPT/CPT-II, Continuous performance test versions I and II; CTL, Control group; CTOPP, Comprehensive test of phonological processing; CWRUS, Case Western Reserve University Study; D-KEFS, Delis-Kaplan Executive Function System; DRWJ, Drexel and Robert Wood Johnson Universities Study; DTVMI, Developmental test of visual-motor integration; IQ, Intelligence quotient; MHPCD, Maternal Health Practices and the Child Development Study; MJ, Marijuana group; NCRR, National Center for Research Resources; NIAAA, National Institute on Alcohol Abuse and Alcoholism; NIDA, National Institute on Drug Abuse; OPPS, Ottawa Prenatal Prospective Study; PACE, Pediatric assessment of cognitive deficiency; PIAT-R, Peabody individual achievement test-revised; PPVT-III/PPVT-R, Peabody picture vocabulary test 3rd and revised editions; SBIS-IV, Stanford-Binet intelligence scale 4th edition; THC, Tetrahydrocannabinol; TOLD-I3, Test of language development-intermediate third edition; TVPS, Test of visual-perceptual skills; WIAT-II, Wechsler individual achievement test 2nd edition; WISC/WISC-III, Wechsler intelligence scale for children 1st and 3rd editions; WRAML, Wide range assessment of memory and learning; WRAT-R, Wide range achievement test-revised.
Negative associations on cognitive outcomes,
Positive associations on cognitive outcomes.